The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells
Open accessAbstract
CD44 is a cell surface adhesion receptor that is highly expressed in many cancers and regulates metastasis via recruitment of CD44 to the cell surface. Its interaction with appropriate extracellular matrix ligands promotes the migration and invasion processes involved in metastases. It was originally identified as a receptor for hyaluronan or hyaluronic acid and later to several other ligands including, osteopontin (OPN), collagens, and matrix metalloproteinases. CD44 has also been identified as a marker for stem cells of several types. Beside standard CD44 (sCD44), variant (vCD44) isoforms of CD44 have been shown to be created by alternate splicing of the mRNA in several cancer. Addition of new exons into the extracellular domain near the transmembrane of sCD44 increases the tendency for expressing larger size vCD44 isoforms. Expression of certain vCD44 isoforms was linked with progression and metastasis of cancer cells as well as patient prognosis. The expression of CD44 isoforms can be correlated with tumor subtypes and be a marker of cancer stem cells. CD44 cleavage, shedding, and elevated levels of soluble CD44 in the serum of patients is a marker of tumor burden and metastasis in several cancers including colon and gastric cancer. Recent observations have shown that CD44 intracellular domain (CD44-ICD) is related to the metastatic potential of breast cancer cells. However, the underlying mechanisms need further elucidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
Todaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., Apuzzo, T., Sperduti, I., Volpe, S., Cocorullo, G., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.009 · Cited by 717
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Podosomes: adhesion hot-spots of invasive cells
Linder, S., & Aepfelbacher, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00128-4 · Cited by 614
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
CD44 is required for two consecutive steps in HGF/c-Met signaling
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Jaggupilli, A., & Elkord, E. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/708036 · Cited by 510
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
Okamoto, I., Kawano, Y., Murakami, D., Sasayama, T., Araki, N., Miki, T., Wong, A. J., & Saya, H. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200108159 · Cited by 372
Heider, K. H., Hofmann, M., Hors, E., van den Berg, F., Ponta, H., Herrlich, P., & Pals, S. T. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.1.227 · Cited by 342
Savani, R. C., Cao, G., Pooler, P. M., Zaman, A., Zhou, Z., & DeLisser, H. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102273200 · Cited by 336
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
The normal structure and function of CD44 and its role in neoplasia
Sneath, R. J., & Mangham, D. C. (1998) · Molecular Pathology · doi:10.1136/mp.51.4.191 · Cited by 332
Mechanism and biological significance of CD44 cleavage
Nagano, O., & Saya, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03179.x · Cited by 325
Katagiri, Y. U., Sleeman, J. P., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita∥, H., Okumura, K., Murakami, M., et al. (1999) · PubMed · Cited by 312
Akech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., van Wijnen, A. J., Stein, J. L., Languino, L. R., Altieri, D. C., et al. (2010) · Oncogene · doi:10.1038/onc.2009.389 · Cited by 295
Cichy, J., & Puré, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302098 · Cited by 277
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Bourguignon, L. W., Zhu, H., Shao, L., & Chen, Y.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006498200 · Cited by 262
Osteopontin: possible role in prostate cancer progression.
Thalmann, G. N., Sikes, R. A., Devoll, R. E., Kiefer, J., Markwalder, R. V., Klima, I., Farach‐Carson, M. C., Studer, U. E., & Chung, L. W. K. (1999) · PubMed · Cited by 261
Okamoto, I., Kawano, Y., Tsuiki, H., Sasaki, J.-I., Nakao, M., Matsumoto, M., Suga, M., Ando, M., Nakajima, M., & Saya, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202447 · Cited by 257
Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength
Chellaiah, M., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D., & Hruska, K. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.665 · Cited by 257
Self-citationDraffin, J. E., McFarlane, S., Hill, A., Johnston, P. G., & Waugh, D. J. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0389 · Cited by 250
Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression
Chellaiah, M. A., Kizer, N., Biswas, R., Alvarez, U., Strauss-Schoenberger, J., Rifas, L., Rittling, S. R., Denhardt, D. T., & Hruska, K. A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0354 · Cited by 249
Self-citationThorne, R. F., Legg, J. W., & Isacke, C. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.00954 · Cited by 244
CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
Williams, K., Motiani, K., Giridhar, P. V., & Kasper, S. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480714 · Cited by 229
Trochon, V., Mabilat, C., Bertrand, P., Legrand, Y., Smadja-Joffe, F., Soria, C., Delpech, B., & Lu, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960529)66:5<664::aid-ijc14>3.0.co;2-4 · Cited by 211
Orian-Rousseau, V., Morrison, H., Matzke, A., Kastilan, T., Pace, G., Herrlich, P., & Ponta, H. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0674 · Cited by 190
Bone tissue remodeling and development: Focus on matrix metalloproteinase functions
Paiva, K. B. S., & Granjeiro, J. M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.034 · Cited by 189
CD44 variant isoforms in head and neck squamous cell carcinoma progression
Wang, S. J., Wong, G., de Heer, A., Xia, W., & Bourguignon, L. Y. W. (2009) · The Laryngoscope · doi:10.1002/lary.20506 · Cited by 181
CD44 as a potential diagnostic tumor marker
Basakran, N. S. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.3.9622 · Cited by 175
Flores Gama, C., Rosales, L. M., Ouellet, G., Dou, Y., Thijssen, S., Usvyat, L., Zhang, H., Kuntsevich, V., Levin, N. W., & Kotanko, P. (2017) · Blood Purification · doi:10.1159/000452731 · Cited by 161
Bourguignon, L., Zhu, H., Shao, L., Zhu, D., & Chen, Y.-W. (1999) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1999)43:4<269::aid-cm1>3.0.co;2-5 · Cited by 158
Wang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.7.771 · Cited by 157
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Desai, B., Rogers, M. J., & Chellaiah, M. A. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-18 · Cited by 157
Self-citationInvolvement of Endothelial CD44 during in Vivo Angiogenesis
Cao, G., Savani, R. C., Fehrenbach, M. L., Lyons, C., Zhang, L., Coukos, G., & DeLisser, H. M. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060206 · Cited by 146
Bourguignon, L., Shiina, M., & Li, J. J. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00010-1 · Cited by 140
Zeilstra, J., Joosten, S. P. J., van Andel, H., Tölg, C., Berns, A. J. M., Snoek, M., van de Wetering, M., Spaargaren, M., Clevers, H. C., & Pals, S. T. (2013) · Oncogene · doi:10.1038/onc.2012.611 · Cited by 140
CD44 Is Involved in Tumor Angiogenesis; an Activation Antigen on Human Endothelial Cells
Griffioen, A. W., Coenen, M. J. H., Damen, C. A., Hellwig, S. M. M., van Weering, D. H. J., Vooys, W. C., Blijham, G. H., & Groenewegen, G. (1997) · Blood · doi:10.1182/blood.v90.3.1150 · Cited by 138
Xu, Y., Swerlick, R. A., Sepp, N. T., Bosse, D. C., Ades, E. W., & Lawley, T. J. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12382086 · Cited by 138
Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD)
Miletti-González, K. E., Murphy, K. A., Kumaran, M. N., Ravindranath, A. K., Wernyj, R. P., Kaur, S., Miles, G. D., Lim, E. T., Chan, R., Chekmareva, M. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318774 · Cited by 136
Tuck, A. B., Chambers, A. F., & Allan, A. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21520 · Cited by 133
CD44 increases the efficiency of distant metastasis of breast cancer
McFarlane, S., Coulter, J. A., Tibbits, P., O’Grady, A., McFarlane, C., Montgomery, N., Hill, A., McCarthy, H. O., Young, L. S., Kay, E. W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3410 · Cited by 119
Khan, S. A., Cook, A. C., Kappil, M., Günthert, U., Chambers, A., Tuck, A., & Denhardt, D. (2006) · Clinical and Experimental Metastasis · doi:10.1007/s10585-006-9007-0 · Cited by 111
Cho, Y., Lee, H.-W., Kang, H.-G., Kim, H., Kim, S.-J., & Chun, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3325 · Cited by 106
Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals
Wang, X., Lee, S. O., Xia, S., Jiang, Q., Luo, J., Li, L., Yeh, S., & Chang, C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0895 · Cited by 103
Wang, S. J., Wreesmann, V. B., & Bourguignon, L. (2007) · Head & Neck · doi:10.1002/hed.20544 · Cited by 102
Desai, B., Ma, T., & Chellaiah, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709401200 · Cited by 95
Self-citationGupta, A., Cao, W., & Chellaiah, M. A. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-66 · Cited by 89
Self-citationCD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
Rall, C., & Rustgi, A. K. (1995) · PubMed · Cited by 82
Gupta, A., Zhou, C. Q., & Chellaiah, M. A. (2013) · Cancers · doi:10.3390/cancers5020617 · Cited by 78
Self-citationOsteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells
Gao, C., Guo, H., Downey, L., Marroquin, C., Wei, J., & Kuo, P. C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg139 · Cited by 78
Desai, B., Ma, T., Zhu, J., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22248 · Cited by 67
Samanna, V., Wei, H., Ego-Osuala, D., & Chellaiah, M. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.022 · Cited by 63
Self-citationExtracellular Molecules Involved in Cancer Cell Invasion
Stivarou, T., & Patsavoudi, E. (2015) · Cancers · doi:10.3390/cancers7010238 · Cited by 55
Wang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.1.19 · Cited by 54
Kuniyasu, H., Oue, N., Tsutsumi, M., Tahara, E., & Yasui, W. (2001) · PubMed · Cited by 48
Soluble CD44 Variant 6 as a Prognostic Indicator in Patients with Colorectal Cancer
Yamane, N., Tsujitani, S., Makino, M., Maeta, M., & Kaibara, N. (1999) · Oncology · doi:10.1159/000011970 · Cited by 48
Expression of CD44 isoforms in human prostate tumor cell lines
Stevens, J. W., Palechek, P. L., Griebling, T. L., Midura, R. J., Rokhlin, O. W., & Cohen, M. B. (1996) · The Prostate · Cited by 46
Gupta, A., Cao, W., Sadashivaiah, K., Chen, W., Schneider, A., & Chellaiah, M. A. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/493689 · Cited by 35
Self-citation
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Superparamagnetic Iron Oxide Nanoparticles—Current and Prospective Medical Applications
Dulińska-Litewka, J., Łazarczyk, A., Hałubiec, P., Szafrański, O., Karnas, K., & Karewicz, A. (2019) · Materials · doi:10.3390/ma12040617 · Cited by 580
Dyrskjøt, L., Hansel, D. E., Efstathiou, J. A., Knowles, M. A., Galsky, M. D., Teoh, J., & Theodorescu, D. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00468-9 · Cited by 544
Metadata
- Authors
- Senbanjo, L. T., & Chellaiah, M. A.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-07
- Volume
- 5
- Pages
- 18-18
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2591862276
- Cited by
- 842
- References
- 63
- FWCI
- 35.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.